Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. [electronic resource] by
- Aghajanian, Carol
- Sill, Michael W
- Darcy, Kathleen M
- Greer, Benjamin
- McMeekin, D Scott
- Rose, Peter G
- Rotmensch, Jacob
- Barnes, Mack N
- Hanjani, Parviz
- Leslie, Kimberly K
Producer: 20110728
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. [electronic resource] by
- Moore, Richard G
- McMeekin, D Scott
- Brown, Amy K
- DiSilvestro, Paul
- Miller, M Craig
- Allard, W Jeffrey
- Gajewski, Walter
- Kurman, Robert
- Bast, Robert C
- Skates, Steven J
Producer: 20090102
In:
Gynecologic oncology vol. 112
Availability: No items available.
|
|
|
49.
|
A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study. [electronic resource] by
- McMeekin, D Scott
- Sill, Michael W
- Darcy, Kathleen M
- Abulafia, Ovadia
- Hanjani, Parviz
- Pearl, Michael L
- Rubin, Stephen C
- Rose, Peter G
- Small, Laurie
- Benbrook, Doris Mangiaracina
Producer: 20130207
In:
Gynecologic oncology vol. 127
Availability: No items available.
|
|
|
50.
|
Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? [electronic resource] by
- Gunderson, Camille C
- Farrell, Regina
- Dinh, Brian C
- Thomas, Eric D
- Vesely, Sara K
- Lauer, Jacob K
- Kao, Lydia
- Chopra, Sheeva
- McMeekin, D Scott
- Moore, Kathleen N
Producer: 20131112
In:
Gynecologic oncology vol. 130
Availability: No items available.
|
|
|
51.
|
Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer. [electronic resource] by
- Mayr, Nina A
- Yuh, William T C
- Jajoura, David
- Wang, Jian Z
- Lo, Simon S
- Montebello, Joseph F
- Porter, Kyle
- Zhang, Dongqing
- McMeekin, D Scott
- Buatti, John M
Producer: 20100316
In:
Cancer vol. 116
Availability: No items available.
|
|
|
52.
|
|
|
|
53.
|
The survival detriment of venous thromboembolism with epithelial ovarian cancer. [electronic resource] by
- Gunderson, Camille C
- Thomas, Eric D
- Slaughter, Katrina N
- Farrell, Regina
- Ding, Kai
- Farris, Ronni E
- Lauer, Jacob K
- Perry, LaToya J
- McMeekin, D Scott
- Moore, Kathleen N
Producer: 20140805
In:
Gynecologic oncology vol. 134
Availability: No items available.
|
|
|
54.
|
Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone. [electronic resource] by
- Tillmanns, Todd D
- Falkner, Camille A
- Engle, David B
- Wan, Jim Y
- Mannel, Robert S
- Walker, Joan L
- Johnson, Gary A
- McMeekin, D Scott
- Zuna, Rosemarry
- Gold, Michael A
Producer: 20060307
In:
Gynecologic oncology vol. 100
Availability: No items available.
|
|
|
55.
|
Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals. [electronic resource] by
- Hocker, James R
- Bishop, Erin A
- Lightfoot, Stan A
- Lerner, Megan R
- Peyton, Marvin D
- Brackett, Daniel J
- Hanas, Rushie J
- McMeekin, D Scott
- Walker, Joan L
- Hanas, Jay S
Producer: 20120522
In:
Cancer investigation vol. 30
Availability: No items available.
|
|
|
56.
|
Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? [electronic resource] by
- Moore, Kathleen N
- Frank, Summer G
- Alward, Erin K
- Landrum, Lisa M
- Myers, Tashanna K
- Walker, Joan L
- Gold, Michael A
- McMeekin, D Scott
- Vesely, Sara K
- Mannel, Robert S
Producer: 20090527
In:
Cancer vol. 115
Availability: No items available.
|
|
|
57.
|
Carcinosarcoma of the ovary-a case series. [electronic resource] by
- Rutledge, Teresa L
- Gold, Michael A
- McMeekin, D Scott
- Huh, Warner K
- Powell, Matthew A
- Lewin, Sharyn N
- Mutch, David G
- Johnson, Gary A
- Walker, Joan L
- Mannel, Robert S
Producer: 20060209
In:
Gynecologic oncology vol. 100
Availability: No items available.
|
|
|
58.
|
A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome. [electronic resource] by
- Morrison, Carl
- Miecznikowski, Jeffrey
- Darcy, Kathleen M
- Dolce, Jean M
- Kandel, Eugene
- Erwin, Deborah O
- Liu, Song
- Shepherd, Lori
- Cohn, David
- McMeekin, D Scott
- Block, Annemarie W
- Nowak, Norma J
- Maxwell, Larry
Producer: 20101025
In:
Genes, chromosomes & cancer vol. 49
Availability: No items available.
|
|
|
59.
|
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study. [electronic resource] by
- Fleming, Gini F
- Sill, Michael W
- Darcy, Kathleen M
- McMeekin, D Scott
- Thigpen, J Tate
- Adler, Lisa M
- Berek, Jonathan S
- Chapman, Julia A
- DiSilvestro, Paul A
- Horowitz, Ira R
- Fiorica, James V
Producer: 20091211
In:
Gynecologic oncology vol. 116
Availability: No items available.
|
|
|
60.
|
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer. [electronic resource] by
- Moore, Kathleen N
- Gunderson, Camille C
- Sabbatini, Paul
- McMeekin, D Scott
- Mantia-Smaldone, Gina
- Burger, Robert A
- Morgan, Mark A
- Kapoun, Ann M
- Brachmann, Rainer Karl
- Stagg, Robert
- Farooki, Azeez
- O'Cearbhaill, Roisin E
Producer: 20191014
In:
Gynecologic oncology vol. 154
Availability: No items available.
|